Cipla Ltd — Profit & Loss Statement

₹1242.30

+0.19%

Cipla Ltd Profit & Loss Statement (Annual)

Metric	2025	2024	2023	2022
Net Income From Continuing And Discontinued Operation	5.27K Cr	4.12K Cr	2.80K Cr	2.52K Cr
Total Expenses	21.00K Cr	20.08K Cr	18.46K Cr	18.05K Cr
Rent Expense Supplemental	111.84 Cr	92.65 Cr	86.86 Cr	78.18 Cr
Diluted Average Shares	80.82 Cr	80.80 Cr	80.76 Cr	80.74 Cr
Basic Average Shares	80.76 Cr	80.73 Cr	80.70 Cr	80.67 Cr
Diluted EPS	65.24	51.01	34.69	31.17
Basic EPS	65.29	51.05	34.72	31.20
Diluted NI Availto Com Stockholders	5.27K Cr	4.12K Cr	2.80K Cr	2.52K Cr
Net Income Common Stockholders	5.27K Cr	4.12K Cr	2.80K Cr	2.52K Cr
Otherunder Preferred Stock Dividend	0.00	0.00	0.00	0.00
Net Income	5.27K Cr	4.12K Cr	2.80K Cr	2.52K Cr
Minority Interests	3.32 Cr	-32.17 Cr	-30.98 Cr	-29.90 Cr
Net Income Including Noncontrolling Interests	5.27K Cr	4.15K Cr	2.83K Cr	2.55K Cr
Net Income Continuous Operations	5.27K Cr	4.15K Cr	2.83K Cr	2.55K Cr
Tax Provision	1.53K Cr	1.55K Cr	1.20K Cr	933.80 Cr
Pretax Income	6.82K Cr	5.70K Cr	4.04K Cr	3.49K Cr
Other Non Operating Income Expenses	54.59 Cr	81.42 Cr	47.75 Cr	53.86 Cr
Special Income Charges	19.92 Cr	-270.00 Cr	-288.11 Cr	-205.16 Cr
Other Special Charges	-131.42 Cr	-34.23 Cr	-21.46 Cr	143.29 Cr
Impairment Of Capital Assets	111.50 Cr	304.23 Cr	127.15 Cr	61.87 Cr
Net Non Operating Interest Income Expense	202.39 Cr	129.71 Cr	52.70 Cr	-26.73 Cr
Total Other Finance Cost	17.99 Cr	18.75 Cr	14.98 Cr	1.50 Cr
Interest Expense Non Operating	44.02 Cr	71.13 Cr	94.56 Cr	104.85 Cr
Interest Income Non Operating	264.40 Cr	219.59 Cr	162.24 Cr	79.62 Cr
Operating Income	6.14K Cr	5.37K Cr	4.02K Cr	3.57K Cr
Operating Expense	11.24K Cr	10.49K Cr	9.49K Cr	8.82K Cr
Other Operating Expenses	2.35K Cr	2.24K Cr	1.82K Cr	1.61K Cr
Depreciation And Amortization In Income Statement	995.45 Cr	941.61 Cr	1.02K Cr	990.08 Cr
Amortization	266.45 Cr	237.87 Cr	314.17 Cr	306.52 Cr
Depreciation Income Statement	729.00 Cr	703.74 Cr	705.02 Cr	683.56 Cr
Research And Development	376.16 Cr	430.46 Cr	385.39 Cr	265.68 Cr
Selling General And Administration	2.96K Cr	2.78K Cr	2.62K Cr	2.48K Cr
Selling And Marketing Expense	1.83K Cr	1.72K Cr	1.69K Cr	1.67K Cr
General And Administrative Expense	1.12K Cr	1.06K Cr	928.14 Cr	811.97 Cr
Rent And Landing Fees	111.84 Cr	92.65 Cr	86.86 Cr	78.18 Cr
Gross Profit	17.38K Cr	15.85K Cr	13.51K Cr	12.39K Cr
Cost Of Revenue	9.76K Cr	9.59K Cr	8.96K Cr	9.23K Cr
Total Revenue	27.15K Cr	25.45K Cr	22.47K Cr	21.62K Cr
Operating Revenue	27.15K Cr	25.45K Cr	22.47K Cr	21.62K Cr
Tax Effect Of Unusual Items	96.17 Cr	5.74 Cr	-43.21 Cr	-33.66 Cr
Tax Rate For Calcs	0.22	0.27	0.30	0.27
Normalized EBITDA	7.43K Cr	6.80K Cr	5.11K Cr	4.71K Cr
Total Unusual Items	428.74 Cr	21.18 Cr	37.38 Cr	-125.92 Cr
Total Unusual Items Excluding Goodwill	428.74 Cr	21.18 Cr	-145.04 Cr	-125.92 Cr
Net Income From Continuing Operation Net Minority Interest	5.27K Cr	4.12K Cr	2.80K Cr	2.52K Cr
Reconciled Depreciation	995.45 Cr	1.05K Cr	1.02K Cr	990.08 Cr
Reconciled Cost Of Revenue	9.76K Cr	9.59K Cr	8.96K Cr	9.23K Cr
EBITDA	7.86K Cr	6.82K Cr	5.15K Cr	4.59K Cr
EBIT	6.86K Cr	5.77K Cr	4.13K Cr	3.60K Cr
Net Interest Income	202.39 Cr	129.71 Cr	52.70 Cr	-26.73 Cr
Interest Expense	44.02 Cr	71.13 Cr	94.56 Cr	104.85 Cr
Interest Income	264.40 Cr	219.59 Cr	162.24 Cr	79.62 Cr
Normalized Income	4.94K Cr	4.11K Cr	3.09K Cr	2.61K Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Cipla Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.